Lipoprotein oxidation, antioxidants and cardiovascular risk: Epidemiologic evidence

Prostaglandins Leukotrienes and Essential Fatty Acids

Volumn 57, Issue 4-5, 1997, Pages 479-487

  Van De Vijver, L P L ^a,b   Kardinaal, A F M ^a   Grobbee, D E ^b,c   Princen, H M G ^a   Van Poppel, G ^a  

^a TNO   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BETA CAROTENE; GLUTATHIONE PEROXIDASE; LOW DENSITY LIPOPROTEIN; SELENIUM;

CONFERENCE PAPER; DIET; DIETARY INTAKE; HUMAN; ISCHEMIC HEART DISEASE; LIPID OXIDATION; PRIORITY JOURNAL; RISK; RISK FACTOR; VITAMIN BLOOD LEVEL;

EID: 0030735945     PISSN: 09523278     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0952-3278(97)90432-4     Document Type: Conference Paper

References (88)

1. Halliwell B. Current status review: free radicals, reactive oxygen species and human disease: a critical evaluation with special reference to atherosclerosis. Br J Exp Path 1989; 70: 737-757.
2. Steinberg D., Parthasarathy S., Carew T. E., Khoo J. C., Witztum J. L. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med 1989; 320: 915-924.
3. Rimm E. B., Stampfer M. J., Ascherio A., Giovannucci E., Colditz G. A., Willett W. C. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med 1993; 328: 1450-1456.
4. Stampfer M. J., Hennekens C. H., Manson J. E., Colditz G. A., Rosner B., Willett W. C. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med 1993; 328: 1444-1449.
5. Halliwell B. Free radicals, antioxidants, and human disease: curiosity, cause or consequence. Lancet 1994; 344: 721-724.
6. Witztum J. L., Steinberg D. Role of oxidized low density lipoprotein in atherogenesis. J Clin Invest 1991; 88: 1785-1792.
7. DiCorleto P. E., Soyombo A. A. The role of the endothelium in atherogenesis. Curr Opin Lipidol 1993; 4: 364-372.
8. Berliner J. A., Haberland M. E. The role of oxidized low-density lipoprotein in atherogenesis. Curr Opin Lipidol 1993; 4: 373-381.
9. Salonen J. T., Ylä-Herttuala S., Yamamoto R., et al. Autoantibody against oxidised LDL and progression of carotid atherosclerosis. Lancet 1992; 339: 883-887.
10. Maggi E., Chiesa R., Melissano G., et al. LDL oxidation in patients with severe carotid atherosclerosis. Arterioscler Thromb 1994; 14: 1892-1899.
11. Chait A., Heinecke J. W. Lipoprotein modification: cellular mechanisms. Curr Opin Lipidol 1994; 5: 365-370.
12. Hennig B., Chow C. K. Lipid peroxidation and endothelial cell injury: implications in atherosclerosis. Free Radic Biol Med 1988; 4: 99-106.
13. Halliwell B., Chirico S. Lipid peroxidation: its mechanism, measurement, and significance. Am J Clin Nutr 1993; 57(suppl)2:715S-725S.
14. Stringer M. D., Görög P. G, Freeman A., Kakkar V. V. Lipid peroxides and atherosclerosis. BMJ 1989; 298: 281-284.
15. Regnström J., Nilsson J., Tornvall P., Landou C., Hamsten A. Susceptibility to low-density oxidation and coronary atherosclerosis in man. Lancet 1992; 339: 1183-1186.
16. De Rijke Y. B., Vogelezang C. J. M., Van Berkel T. J. C., et al. Suscepitibility of low-density lipoprotein to oxidation in coronary bypass patients. Lancet 1992; 340: 858-859.
17. Cominacini L, Garbini U., Pastorino A. M., et al. Predisposition to LDL oxidation in patients with and without angiography established coronary artery disease. Atherosclerosis 1993; 99: 63-70.
18. 2-isoprostanes) in smokers. N Engl J Med 1995; 332: 1198-1203.
19. Vijver L. P. L. van de, Steyger R., Van Poppel G., et al. Autoantibodies against MDA-LDL in subjects with severe and minor atherosclerosis and healthy population controls. Atherosclerosis 1996; 122: 245-253.
20. Virella G., Virella I., Leman R. B., Pryor M. B., Lopes-Virella M. F. Anti-oxidized low density lipoprotein antibodies in patients with coronary heart disease and normal healthy volunteers. Int J Clin Lab Res 1993; 23: 95-101.
21. Gey K. F., Brubacher G. B., Stähelin H. B. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am J Clin Nutr 1987; 45: 1368-1377.
22. Gey K. F., Puska P., Jordan P., Moser U. K. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am J Clin Nutr 1991; 53: 3265-3345.
23. Bellizzi M. C., Franklin M. F., Duthy G. G., James W. P. T. Vitamin E and coronary heart disease: the European paradox. Eur J Clin Nutr 1994; 48: 822-831.
24. Salonen J. T., Salonen R., Seppänen K, et al. Relationship of serum selenium and antioxidants to plasma lipoproteins, platelet aggregability and prevalent ischaemic heart disease in Eastern Finnish men. Atherosclerosis 1988; 70: 155-160.
25. Riemersma R. A., Wood D. A., Macintyre C. C. A., Elton R. A., Gey K. F., Oliver M. F. Risk of angina pectoris and plasma concentrations of vitamins A, C, and E and carotene. Lancet 1991; 337: 1-5.
26. Kardinaal A. F. M., Kok F. J., Ringstad J., et al. Antioxidants in adipose tissue and risk of myocardial infarction: the Euramic study. Lancet 1993; 342: 1379-1384.
27. Gey K. F., Stähelin H. B., Eichholzer M. Poor plasma status of carotene and vitamin C is associated with higher mortality from ischemic heart disease and stroke. Clin Invest 1993; 71:3-6.
28. Kok F. J., de Bruijn A. M., Vermeeren R., et al. Serum selenium, vitamin antioxidants and cardiovascular mortality: a 9-year follow-up study in the Netherlands. Am J Clin Nutr 1987; 45: 462-468.
29. Hense H. W., Stender M., Bors W., Keil U. Lack of an association between serum vitamin E and myocardial infarction in a population with high vitamin E levels. Atherosclerosis 1993; 103: 21-28.
30. Kushi L. H., Folsom A. R., Prineas R. J., Mink P. J., Wu Y., Bostick R. M. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med 1996; 334: 1156-1162.
31. Knekt P., Reunanen A., Järvinen R., Seppänen R., Heliövaara M., Aromaa A. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol 1994; 139: 1180-1189.
32. Kritchevsky S. B., Shimakawa T., Tell G. S., et al. Dietary antioxidants and carotid artery wall thickness: the ARIC study. Circulation 1995; 92: 2142-2150.
33. Hodis H. N., Mack W. J., LaBree L., et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA 1995; 273: 1849-1854.
34. Armstrong B. K., Mann J. I., Adelstein A. M., Eskin F. Commodity consumption and ischemic heart disease mortality, with special reference to dietary practices. J Chron Dis 1975; 28: 455-469.
35. Knox E. G. Ischaemic-heart-disease mortality and dietary intake of calcium. Lancet 1973; ii: 1465-1467.
36. Gale C. R., Martyn C. N., Winter P. D., Cooper C. Vitamin C and risk of death from stroke and coronary heart disease in cohort of elderly people. BMJ 1995; 310: 1563-1566.
37. Enstrom J. E., Kanim L. E., Klein M. A. Vitamin C intake and mortality among a sample of the United States population. Epidemiology 1992; 3: 194-202.
38. Palgi A. Association between dietary changes and mortality rates: Israël 1949 to 1977; a trend-free regression model. Am J Clin Nutr 1981; 34: 1569-1583.
39. Gramenzi A., Gentile A., Fasoli M., Negri E., Parazzini F., La Vecchia C. Association between certain foods and risk of acute myocardial infarction in women. Br Med J 1990; 300: 771-773.
40. Pandey D. K., Shekelle R., Selwyn B. J., Tangney C., Stamler J. Dietary vitamin C and β-carotene and risk of death in middle-aged men; the western electric study. Am J Epidemiol 1995; 142: 1269-1278.
41. Street D. A., Comstock G. W., Salkeld R. M., Schüep W., Klag M. J. Serum antioxidants and myocardial infarction; are low levels of carotenoids and α-tocopherol risk factors for myocardial infarction. Circulation 1994; 90: 1154-1161.
42. Morris D. L., Kritchevsky S. B., Davis C. E. Serum carotenoids and coronary heart disease. JAMA 1994; 272: 1439-1441.
43. Greenberg E. R., Baron J. A., Karagas M. R., et al. Mortality associated with low plasma concentration of beta carotene and the effect of oral supplementation. JAMA 1996; 275: 699-703.
44. Kok F. J., Hofman A., Witteman J. C. M., et al. Decreased selenium levels in acute myocardial infarction. JAMA 1989; 261: 1161-1164.
45. Salonen J. T., Alfthan G., Huttunen J. K., Pikkarainen J., Puska P. Association between cardiovascular death and myocardial infarction and serum selenium in a matched-pair longitudinal study. Lancet 1982; ii: 175-179.
46. Virtamo J., Valkeila E., Alfthan G., Punsar S., Huttunen J. K., Karvonen M. J. Serum selenium and the risk of coronary heart disease and stroke. Am J Epidemiol 1985; 122: 276-282.
47. Suadicani P., Hein H. O., Gyntelberg F. Serum selenium concentration and risk of ischaemic heart disease in a prospective cohort study of 3000 males. Atherosclerosis 1992; 96: 33-42.
48. Salonen J. T. Selenium in ischaemic heart disease. Int J Epidemiol 1987; 16: 323-328.
49. Kardinaal A. F. M., Kok F. J., Kohlmeier L., et al. Association between toenail selenium and risk of acute myocardial infarction in European men; the EURAMIC study. Am J Epidemiol 1997; 145: 373-379.
50. Kardinaal A. F. M., Van't Veer P., Brants H. A. M., Van den Berg H., Van Schoonhoven J., Hermus R. J. J. Relations between antioxidant vitamins in adipose tissue, plasma, and diet. Am J Epidemiol 1995; 141: 440-450.
51. Carew T. E., Schwenke D. C., Steinberg D. Antiatherogenic effect of probucol unrelated to its hypocholesterolemic effect. Evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. Proc Natl Acad Sci USA 1987; 84: 7725-7729.
52. Williams R. J., Motteram J. M., Sharp C. H., Gallagher P. J. Dietary vitamin E and the attenuation of early lesion development in modified Watanabe rabbits. Atherosclerosis 1992; 94: 153-159.
53. Prasad K., Kalra J. Oxygen free radicals and hypercholesterolemic atherosclerosis: effect of vitamin E. Am Heart J 1993; 125: 958-973.
54. Princen H. M. G., van Duyvenvoorde W., Buytenhek R., et al. Supplementation with low doses of vitamin E protects LDL from lipid peroxidation in men and women. Arterioscler Thromb Vasc Biol 1995; 15: 325-333.
55. Willingham A. K., Bolanos C., Bohanna E., Cenedella R. J. The effects of high levels of vitamin E on the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit. J Nutr Biochem 1993; 4: 651-654.
56. Wójcicki J., Rózewicka L., Barcew-Wiszniewska B., et al. Effect of selenium and vitamin E on the development of experimental atherosclerosis in rabbits. Atherosclerosis 1991; 87: 9-16.
57. Verlangieri A. J., Bush M. J. Effects of d-α-tocopherol supplementation on experimentally induced primate atherosclerosis. J Am Coll Nutr 1992; 11: 131-138.
58. Simon J. A. Vitamin C and cardiovascular disease: a review. J Am Coll Nutr 1992; 11: 107-125.
59. Keaney J. F., Gaziano J. M., Xu A., et al. Dietary antioxidants preserve endothelium-dependent vessel relaxation in cholesterol-fed rabbits. Proc Natl Acad Sci USA 1993; 90: 11880-11884.
60. Keaney J. F., Gaziano J. M., Xu A., et al. Low-dose α-tocopherol improves and high-dose α-tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J Clin Invest 1994; 93: 844-851.
61. Shaish A., Daugherty A., Osullivan F., Schonfeld G., Heinecke J. W. Beta-carotene inhibits atherosclerosis in hypercholesterolemic rabbits. J Clin Invest 1995; 96: 2075-2082.
62. Salonen J. T. Antioxidants and platelets. Ann Med 1989; 21: 59-62.
63. Kleijnen J., Knipschild P., ter Riet G. Vitamin E and cardiovascular disease. Eur J Clin Pharmacol 1989; 37: 541-544.
64. Princen H. M. G., van Poppel G., Vogelezang C., Buytenhek R., Kok F. J. Supplementation of vitamin E, but not of β-carotene in vivo protects LDL from peroxidation in vitro. Effect of cigarette smoking. Arterioscler Thromb 1992; 12: 554-562.
65. Dieber-Rotheneder M., Puhl H., Waeg G., Striegl G., Esterbauer H. Effect of oral supplementation with D-α-tocopherol on the vitamin E content of human low density lipoproteins and resistance to oxidation. J Lipid Res 1991; 32: 1325-1332.
66. Jialal I., Grundy S. M. Influence of antioxidant vitamins on LDL oxidation. Ann NY Acad Sci 1992; 669: 237-248.
67. Reaven P. D., Khouw A., Beltz W. F., Parthasarathy S., Witztum J. L. Effect of dietary antioxidant combinations in humans. Protection of LDL by vitamin E but not by β-carotene. Arterioscler Thromb 1993; 13: 590-600.
68. Nyyssönen K., Porkkale E., Salonen R., Korpela H., Salonen J. T. Increase in oxidation resistance of atherogenic serum lipoproteins following antioxidant supplementation: a randomized double-blind placebo-controlled clinical trial. Eur J Clin Nutr 1994; 48: 633-642.
69. DeMaio S. J., King S. B., Lembo N. J., et al. Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J Am Coll Nutr 1992; 11: 68-73.
70. Trout D. L. Vitamin C and cardiovascular risk factors. Am J Clin Nutr 1991; 53: 322S-325S.
71. Ringer T. V., DeLoof M. J., Winterrowd G. E., et al. Beta-carotene's effects on serum lipoproteins and immunologic indices in humans. Am J Clin Nutr 1991; 53: 688-694.
72. Nierenberg D. W., Bayrd G. T., Stukel T. A. Lack of effect of chronic administration of oral β-carotene on serum cholesterol and triglyceride concentrations. Am J Clin Nutr 1991; 53: 652-654.
73. van Poppel G. Hospers J., Buytenhek R., Princen H. M. G. No effect of β-carotene supplementation on lipoproteins in healthy smokers. Am J Clin Nutr 1994; 60: 730-734.
74. Burton G. W., Ingold K. U. β-carotene: an unusual kind of lipid antioxidant. Science 1984; 224: 569-573.
75. Allard J. P., Royall D., Kurian R., Muggli R., Jeejeebhoy K. N. Effect of β-carotene supplementation on lipid peroxidation in humans. Am J Clin Nutr 1994; 59: 884-890.
76. Walldius G., Erikson U., Olsson A. G., et al. The effect of probucol on femoral atherosclerosis: the Probucol Quantitative Regression Swedish Trial (PQRST). Am J Cardiol 1994; 74: 875-883.
77. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N Engl J Med 1994; 330: 1019-1035.
78. Stephens N. G., Parsons A., Schofield P. M., et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 1996; 347: 781-86.
79. Omenn G. S., Goodman G. E., Thornquist M. D., et al. Effects of a combination of beta carotene and vitamin A on lung cancer and cardiovascular disease. N Engl J Med 1996; 334: 1150-1155.
80. Hennekens C. H., Buring J. E., Manson J. E., et al. Lack of effect of long-term supplementation with beta carotene on the incidence of malignant neoplasms and cardiovascular disease. N Engl J Med 1996; 334: 1145-1149.
81. Rapola J. M., Virtamo J., Haukka J. K., et al. Effect of vitamin E and beta carotene on the incidence of angina pectoris a randomized, double-blind, controlled trial. JAMA 1996; 275: 693-98.
82. Frankel E. N., Kanner J., German J. B., Parks E., Kinsella J. E. Inhibition of oxidation of human low-density lipoprotein by phenolic substances in red wine. Lancet 1993; 341: 454-457.
83. Hertog M. G. L., Feskens E. J. M., Hollman P. C. H., Katan M. B., Kromhout D. Dietary antioxidant flavonoids and risk of coronary heart disease: the Zutphen Elderly Study. Lancet 1993; 342: 1007-1011.
84. Salonen J. T., Nyyssönen K., Korpela H., Tuomilehto J., Seppanen R., Salonen R. High stored iron levels are associated with excess risk of myocardial infarction in Eastern Finnish men. Circulation 1992; 86: 803-811.
85. Parthasarathy S., Khoo J. C., Miller E., Barnett J., Witztum J. L., Steinberg D. Low density lipoprotein rich in oleic acid is protected against oxidative modification; implications for dietary prevention of atherosclerosis. Proc Natl Acad Sci USA 1990; 87: 3894-3898.
86. Bonanome A., Pagnan A., Biffanti S., et al. Effect of dietary monounsaturated and polyunsaturated fatty acids on the susceptibility of plasma low density lipoproteins to oxidative modification. Arterioscler Thromb 1992; 12: 529-533.
87. Jha P., Flather M., Lonn E., Farkouh M., Yusuf S. The antioxidant vitamins and cardiovascular disease a critical review of epidemiologic and clinical trial data. Ann Intern Med 1995; 123: 860-872.
88. Blot W. J., Li J.-Y., Taylor P. R., et al. Nutrition intervention trials in Linxian, China: supplementation with specific vitamin/mineral combinations, cancer incidence, and disease-specific mortality in the general population. J Natl Cancer Inst 1993; 85: 1483-1492.